At day 28 , 74 of 165 patients ( 45 % ) in the steroid group and 87 of 163 ( 53 % ) in the placebo group had developed one or more episodes of hospital-acquired pneumonia ( hazard ratio [ HR ] 0.75 ; 95 % CI 0.55-1 .03 , p = 0.07 ) .